CRP and breast carcinoma: <h4>Background</h4>Systemic inflammatory biomarkers such as C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) are increasingly studied in breast cancer, but their within-treatment dynamics and relationship with anthropometric context during chemotherapy remain underexplored.